UB Paderborn / Katalog / Suche / in CDI

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome

Diabetes, obesity & metabolism, 2013-06, Vol.15 (6), p.513-522

2013

Link zum Volltext

Verfügbarkeit prüfen

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

American journal of hypertension, 1999-08, Vol.12 (8), p.797-805

1999

Link zum Volltext

Verfügbarkeit prüfen

Ground-state properties of a one-dimensional system of hard-core bosons in a harmonic trap

Physical review. A, Atomic, molecular, and optical physics, 2001-03, Vol.63 (3), Article 033601

2001

Link zum Volltext

Verfügbarkeit prüfen

Statistical Characterization of the Charge State and Residue Dependence of Low-Energy CID Peptide Dissociation Patterns

Analytical chemistry (Washington), 2005-09, Vol.77 (18), p.5800-5813

2005

Link zum Volltext

Verfügbarkeit prüfen

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Vascular health and risk management, 2015-01, Vol.11 (default), p.165-172

2015

Link zum Volltext

Verfügbarkeit prüfen

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects

Clinical neuropharmacology, 1991-06, Vol.14 (3), p.256-261

1991

Link zum Volltext

Verfügbarkeit prüfen

Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin

American journal of physiology. Regulatory, integrative and comparative physiology, 1987-03, Vol.252 (3), p.471-R478

1987

Link zum Volltext

Verfügbarkeit prüfen

Single-Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment

Journal of clinical pharmacology, 1992-02, Vol.32 (2), p.124-132

1992

Link zum Volltext

Verfügbarkeit prüfen

Relationship between sympathetic activity and diet-induced obesity in two rat strains

American journal of physiology. Regulatory, integrative and comparative physiology, 1983-09, Vol.245 (3), p.364-371

1983

Link zum Volltext

Verfügbarkeit prüfen

Dissociation Behavior of Doubly-Charged Tryptic Peptides: Correlation of Gas-Phase Cleavage Abundance with Ramachandran Plots

Journal of the American Chemical Society, 2004-03, Vol.126 (10), p.3034-3035

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic interaction between propranolol and the HMG‐CoA reductase inhibitors pravastatin and lovastatin

British journal of clinical pharmacology, 1991-06, Vol.31 (6), p.665-670

1991

Link zum Volltext

Verfügbarkeit prüfen

Altered sympathetic activity during development of diet-induced obesity in rat

American journal of physiology. Regulatory, integrative and comparative physiology, 1983-03, Vol.244 (3), p.347-R355

1983

Link zum Volltext

Verfügbarkeit prüfen

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan

Clinical therapeutics, 1998-05, Vol.20 (3), p.398-409

1998

Link zum Volltext

Verfügbarkeit prüfen

Metabolic features of diet-induced obesity without hyperphagia in young rats

American journal of physiology. Regulatory, integrative and comparative physiology, 1986-09, Vol.251 (3), p.433-R440

1986

Link zum Volltext

Verfügbarkeit prüfen

Steady state serum concentrations of pravastatin and digoxin when given in combination

British journal of clinical pharmacology, 1993-09, Vol.36 (3), p.263-265

1993

Link zum Volltext

Verfügbarkeit prüfen

Pravastatin and lovastatin in cerebrospinal fluid

Clinical neuropharmacology, 1993-12, Vol.16 (6), p.559-560

1993

Link zum Volltext

Verfügbarkeit prüfen

Metabolic regulation as a control for lipid disorders. I. Influence of (—)-hydroxycitrate on experimentally induced obesity in the rodent

The American journal of clinical nutrition, 1977-05, Vol.30 (5), p.767-776

1977

Link zum Volltext

Verfügbarkeit prüfen

Metabolic regulation as a control for lipid disorders, 1: Influence of (-)-hydroxycitrate on experimentally induced obesity in the rodent

The American journal of clinical nutrition, 1977, Vol.30

1977

Link zum Volltext

Verfügbarkeit prüfen

Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat

American journal of physiology: endocrinology and metabolism, 1981-01, Vol.240 (1), p.E72-E78

1981

Link zum Volltext

Verfügbarkeit prüfen

Brown adipose and metabolic features of chronic diet-induced obesity

American journal of physiology. Regulatory, integrative and comparative physiology, 1985-06, Vol.248 (6), p.717-R723

1985

Link zum Volltext

Verfügbarkeit prüfen

Studies of origins of abnormal sympathetic function in obese Zucker rats

American journal of physiology: endocrinology and metabolism, 1983-07, Vol.245 (1), p.E87-E93

1983

Link zum Volltext

Verfügbarkeit prüfen

87 EZETIMIBE/SIMVASTATIN 10/40MG VERSUS ATORVASTATIN 40MG IN HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY

Atherosclerosis. Supplements, 2011-06, Vol.12 (1), p.21-21

2011

Link zum Volltext

Verfügbarkeit prüfen

Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654

Journal of lipid research, 1985-10, Vol.26 (10), p.1196-1204

1985

Link zum Volltext

Verfügbarkeit prüfen

Anti-obesity activity of a novel lipid synthesis inhibitor

International journal of obesity, 1984, Vol.8 Suppl 1, p.227

1984

Link zum Volltext

Verfügbarkeit prüfen

Changes in lipid metabolism in diet-induced obesity

Metabolism, clinical and experimental, 1985-06, Vol.34 (6), p.580-587

1985

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

Ground-state properties of a one-dimensional system of hard-core bosons in a harmonic trap

Statistical Characterization of the Charge State and Residue Dependence of Low-Energy CID Peptide Dissociation Patterns

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects

Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin

Single-Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment

Relationship between sympathetic activity and diet-induced obesity in two rat strains

Dissociation Behavior of Doubly-Charged Tryptic Peptides: Correlation of Gas-Phase Cleavage Abundance with Ramachandran Plots

Pharmacokinetic interaction between propranolol and the HMG‐CoA reductase inhibitors pravastatin and lovastatin

Altered sympathetic activity during development of diet-induced obesity in rat

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan

Metabolic features of diet-induced obesity without hyperphagia in young rats

Steady state serum concentrations of pravastatin and digoxin when given in combination

Pravastatin and lovastatin in cerebrospinal fluid

Metabolic regulation as a control for lipid disorders. I. Influence of (—)-hydroxycitrate on experimentally induced obesity in the rodent

Metabolic regulation as a control for lipid disorders, 1: Influence of (-)-hydroxycitrate on experimentally induced obesity in the rodent

Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat

Brown adipose and metabolic features of chronic diet-induced obesity

Studies of origins of abnormal sympathetic function in obese Zucker rats

87 EZETIMIBE/SIMVASTATIN 10/40MG VERSUS ATORVASTATIN 40MG IN HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY

Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654

Anti-obesity activity of a novel lipid synthesis inhibitor

Changes in lipid metabolism in diet-induced obesity

Suchergebnisse filtern